Therabron Therapeutics to Present at BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference

ROCKVILLE, Md., Feb. 23, 2016 /PRNewswire/ -- Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive Officer, Dr. Thomas F. Miller, will give a corporate presentation at the BioCentury 23^rd Annual Future Leaders in the Biotech Industry Conference.  Additional information is as follows:

About Therabron Therapeutics, Inc.
At Therabron Therapeutics, we are advancing a platform of novel therapeutic proteins in an effort to change how a variety of neglected and under-treated respiratory and fibrotic conditions are managed.  We are a privately held, clinical-stage, biopharmaceutical company, developing a new class of drugs based on the naturally occurring secretoglobin family of proteins which includes the CC10 protein -- a molecule with both anti-inflammatory and immunomodulatory mechanisms.  Therabron's product candidates have the potential to become first-in-class, biologic therapeutics.  For additional information, please visit www.therabron.com.

SOURCE Therabron Therapeutics, Inc.

Related Links

http://www.therabron.com